Us Advisors Wealth Management, LLC Abb Vie Inc. Transaction History

Us Advisors Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $100,549 - $125,808	-1,394 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $273,837 - $329,230	-4,348 Reduced 75.72%	1,394 $105,000
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $24,111 - $30,820	-367 Reduced 6.01%	5,742 $418,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $308 - $363	4 Added 0.07%	6,109 $492,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $311 - $384	4 Added 0.07%	6,105 $563,000
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $58,413 - $64,937	-657 Reduced 9.72%	6,101 $577,000
Q2 2018 Oct 10, 2018	BUY	$89.78 - $106.23 $59,434 - $70,324	662 Added 10.86%	6,758 $626,000
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $184 - $246	2 Added 0.03%	6,096 $577,000
Q4 2017 Mar 28, 2018	BUY	$89.56 - $98.21 $545,778 - $598,491	6,094	6,094 $0

3,760

1.28B

13M

9.83M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $356B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Us Advisors Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Us Advisors Wealth Management, LLC with notifications on news.